PCBL Chemical Limited
NSE: PCBLCarbon Black
Share price
₹319.25
-2.34% close of 8 Oct 2026
Business score
How strong the business is, in one number. The parts behind it are in Pro.
45
out of 100 · worked out 8 Oct 2026
Your ratios
The numbers you want to see first. Tap Edit to change them.
Market cap
₹12,451 Cr
P/E ratio
47.0
P/B ratio
3.1
ROCE
7.8%
ROE
5.6%
Dividend yield
1.9%
Price & valuation chart
How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.
Answers
Simple answers to the questions investors ask most, from the company's own numbers.
How fast it has been growing
Sales grew 2.1% over the past year, and 11.3% a year over its longer record. Meanwhile what it keeps of every 100 rupees of sales slipped from 14.2% to 12.9% over the last four years.
Whether it grew faster than its sector
It grew 11.3% a year against a sector median of 10.2% — 1.1 percentage points faster.
Room to re-rate, or risk of de-rating
At 47.0× earnings it costs 2.0× the market, which pays 23.9× across 2199 companies we can price. Its own industry sits at 56.2×, across 5 companies. It is against its own five-year median of 22.8×, the 92nd percentile of its own range.
Whether growth justifies the valuation
Its earnings are falling, so growth cannot justify the price.
| Profit growth | Price per ₹1 profit | Per 1% growth | |
|---|---|---|---|
| PCBL Chemical Limited — this one | -21%/yr | 47.0× | — |
| Solar Industries India Limited | 30%/yr | 89.8× | ₹3.0 |
| Pidilite Industries | 25%/yr | 56.2× | ₹2.2 |
| SRF Limited | -4%/yr | 32.9× | — |
| Linde India Limited | 1%/yr | 93.8× | ₹93.8 |
| Coromandel International Limited | -1%/yr | 26.9× | — |
Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
How it compares with its peers
Against companies across the whole Chemicals sector, it ranks 123 of 182 on returns, 75 of 175 on growth, 73 of 182 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
What makes it hard to beat — and is that still true?
No durable advantage shows in the numbers: it earns 7.8% on capital, ahead of 32% of companies across its whole sector. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
Whether its growth pays for itself
Yes — Over the last five years it made ₹4235 crore of cash from the business and spent ₹3223 crore on plant and equipment, with ₹1012 crore to spare; it still raised ₹2513 crore mostly borrowed — borrowings rose from ₹786 crore to ₹4989 crore. And the profit is real: of every 100 rupees it reported over 12 years, about 198 arrived as cash — well above the profit; depreciation and interest are the reason, not a windfall. Its cash comes back faster than it used to: it went from being waiting 17 days for its cash to paid 40 days before it paid its own suppliers.
Profit reality check
Is the profit real cash? Simple checks on the accounts. Facts only, not advice.
8 of 9 checks clear · 89%
Latest result · Q1 FY27
What the last results showed. Whether management kept its word is in Pro.
Profit grew 65% but carbon black volumes were flat against the high single-digit growth guided.
Announced 29 Jul 2026 · Consolidated
Revenue
₹2,473 Cr
Revenue vs last year
+17.0%
Revenue vs last quarter
+19.7%
Net profit
₹155 Cr
Profit vs last year
+64.8%
Profit vs last quarter
+287.3%
Net margin
6.3%
EPS
₹3.94
Earnings call transcript · 29 Jul 2026
Checklist before you investPRO
Points for and against, in one list.
Key numbers & peers
The main numbers grouped by topic, and how the company compares with similar ones.
Price
- Market cap
- ₹12,451 Cr
- Prev close
- ₹319.25
- 52w High
- ₹393
- 52w Low
- ₹227
- Enterprise value
- ₹17,152 Cr
- Beta
- 1.7
- Price CAGR 1y
- -16.0%
- Price CAGR 3y
- 18.0%
- Price CAGR 5y
- 21.0%
- Price CAGR 10y
- 28.0%
Ratios
- Return on assets
- 1.8%
- PEG ratio
- -2.3
- P/E ratio
- 47.0
- P/B ratio
- 3.1
- EV / EBITDA
- 15.3
- Industry P/E
- 22.1
- ROCE
- 7.8%
- ROCE 5y average
- 13.8%
- ROE
- 5.6%
- Debt / Equity
- 1.2
- Interest coverage
- 1.6
- Dividend yield
- 1.9%
- ROE 3y average
- 11.0%
- ROE last year
- 6.0%
Annual P&L
- Annual revenue
- ₹8,189 Cr
- Annual profit
- ₹198 Cr
- Operating margin
- 13.0%
- Net profit margin
- 2.4%
- EBITDA margin
- 12.7%
- Sales growth 3y
- 12.4%
- Sales growth 5y
- 25.2%
- Profit growth 3y
- -21.0%
- Profit growth 5y
- -7.0%
- EPS
- ₹5.0
- Sales growth TTM
- 2.0%
- Profit growth TTM
- -36.0%
- Dividend payout
- 119.0%
Quarter P&L
- Sales latest quarter
- ₹2,473 Cr
- Profit latest quarter
- ₹155 Cr
- YoY quarterly sales growth
- 17.0%
- YoY quarterly profit growth
- 64.9%
- OPM latest quarter
- 16.0%
Balance Sheet
- Book Value
- ₹103
- Face Value
- ₹1.0
- Total debt
- ₹4,989 Cr
- Total cash
- ₹288 Cr
- Borrowings
- ₹4,989 Cr
- Reserves / Equity
- 101.7
Cash Flow
- Operating cash flow
- ₹1,576 Cr
- Free cash flow
- ₹851 Cr
- FCF yield
- 3.4%
- Net cash flow
- -₹89 Cr
Shareholding
- Promoter holding
- 53.4%
- FII holding
- 5.8%
- DII holding
- 11.3%
- Public holding
- 28.4%
Peer comparison
| Company | Price ₹ | P/E | Mkt cap ₹ Cr | Div yield % | Profit qtr ₹ Cr | Profit var % | Sales qtr ₹ Cr | Sales var % | ROCE % |
|---|---|---|---|---|---|---|---|---|---|
| Himadri Special | 660.55 | 41.7 | 33,330 | 0.12 | 228.4 | 26.3 | 1,431.9 | 28.0 | 22.1 |
| PCBL Chemical | 321.40 | 47.8 | 12,646 | 1.90 | 154.9 | 64.8 | 2,473.4 | 17.0 | 7.8 |
| Median | 490.97 | 44.8 | 22,988 | 1.01 | 191.7 | 45.5 | 1,952.6 | 22.5 | 14.9 |
Competes with: Himadri Speciality Chemical Limited
Quarterly results
Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.
| Line item | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,348 | 1,487 | 1,657 | 1,929 | 2,144 | 2,163 | 2,010 | 2,087 | 2,114 | 2,164 | 1,846 | 2,066 | 2,473 |
| Expenses | 1,137 | 1,249 | 1,378 | 1,619 | 1,785 | 1,800 | 1,693 | 1,790 | 1,795 | 1,897 | 1,631 | 1,823 | 2,078 |
| Material Cost | 1,454 | 1,447 | 1,497 | 1,350 | 1,380 | 1,767 | |||||||
| Change in Inventories | 22 | -2.75 | 28 | -65 | 71 | -117 | |||||||
| Purchases of Stock-in-Trade | 1.15 | 9.89 | 3.48 | 0.24 | 0.11 | 0.16 | |||||||
| Employee Cost | 109 | 109 | 124 | 116 | 113 | 130 | |||||||
| Other Expenses | 204 | 231 | 244 | 230 | 259 | 297 | |||||||
| Operating Profit | 211 | 238 | 279 | 310 | 358 | 364 | 317 | 298 | 319 | 266 | 215 | 243 | 396 |
| OPM % | 16 | 16 | 17 | 16 | 17 | 17 | 16 | 14 | 15 | 12 | 12 | 12 | 16 |
| Other Income | 4 | 3 | 7 | 23 | 11 | 6 | 11 | 20 | 6 | 12 | -5 | 0 | 4 |
| Exceptional items (within Other Income) | 0 | 0 | 0 | -21 | -4.19 | 0 | |||||||
| Interest | 19 | 21 | 32 | 108 | 121 | 119 | 118 | 103 | 112 | 107 | 106 | 97 | 93 |
| Depreciation | 41 | 48 | 53 | 75 | 84 | 86 | 87 | 88 | 92 | 93 | 94 | 94 | 103 |
| Profit before tax | 154 | 172 | 201 | 149 | 164 | 164 | 124 | 126 | 120 | 78 | 10 | 52 | 204 |
| Tax % | 29 | 28 | 26 | 26 | 28 | 25 | 25 | 21 | 22 | 21 | 80 | 23 | 24 |
| Net Profit | 109 | 123 | 148 | 111 | 118 | 123 | 93 | 100 | 94 | 62 | 2 | 40 | 155 |
| EPS in Rs | 2.89 | 3.25 | 3.92 | 2.95 | 3.13 | 3.27 | 2.47 | 2.65 | 2.49 | 1.63 | 0.05 | 1.02 | 3.94 |
| Diluted EPS in Rs | 2.64 | 2.48 | 1.62 | 0.05 | 1.02 | 3.94 |
Profit & loss
Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.
| Line item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,470 | 1,894 | 1,927 | 2,558 | 3,529 | 3,244 | 2,660 | 4,446 | 5,774 | 6,420 | 8,404 | 8,189 | 8,549 |
| Expenses | 2,319 | 1,729 | 1,662 | 2,175 | 2,912 | 2,778 | 2,143 | 3,793 | 5,043 | 5,383 | 7,067 | 7,146 | 7,429 |
| Material Cost | 5,836 | 5,674 | |||||||||||
| Change in Inventories | -44 | 31 | |||||||||||
| Purchases of Stock-in-Trade | 17 | 14 | |||||||||||
| Employee Cost | 413 | 463 | |||||||||||
| Other Expenses | 845 | 964 | |||||||||||
| Operating Profit | 151 | 165 | 265 | 383 | 616 | 465 | 517 | 653 | 731 | 1,037 | 1,337 | 1,043 | 1,119 |
| OPM % | 6 | 9 | 14 | 15 | 17 | 14 | 19 | 15 | 13 | 16 | 16 | 13 | 13 |
| Other Income | 14 | 16 | 12 | 23 | 20 | 28 | 19 | 28 | 41 | 37 | 47 | 14 | 12 |
| Exceptional items (within Other Income) | -0.52 | -25 | |||||||||||
| Interest | 95 | 72 | 51 | 41 | 37 | 46 | 34 | 29 | 53 | 181 | 461 | 423 | 403 |
| Depreciation | 58 | 62 | 61 | 61 | 66 | 92 | 110 | 121 | 137 | 217 | 346 | 373 | 384 |
| Profit before tax | 12 | 47 | 165 | 304 | 533 | 355 | 392 | 532 | 582 | 676 | 577 | 261 | 345 |
| Tax % | 14 | 66 | 58 | 24 | 28 | 19 | 20 | 20 | 24 | 27 | 25 | 24 | |
| Net Profit | 10 | 16 | 69 | 230 | 383 | 288 | 314 | 426 | 442 | 491 | 435 | 198 | 259 |
| EPS in Rs | 0.31 | 0.46 | 2.01 | 6.64 | 11 | 8.31 | 9.10 | 11 | 12 | 13 | 12 | 5.03 | 6.64 |
| Diluted EPS in Rs | 11 | 5.13 | |||||||||||
| Dividend Payout % | 32 | 54 | 30 | 11 | 16 | 42 | 38 | 44 | 47 | 42 | 48 | 119 |
Compounded growth
Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.
Compounded sales growth
- 10 years
- 16%
- 5 years
- 25%
- 3 years
- 12%
- TTM
- 2%
Compounded profit growth
- 10 years
- 31%
- 5 years
- -7%
- 3 years
- -21%
- TTM
- -36%
Stock price CAGR
- 10 years
- 28%
- 5 years
- 21%
- 3 years
- 18%
- 1 year
- -16%
Return on equity
- 10 years
- 14%
- 5 years
- 13%
- 3 years
- 11%
- Last year
- 6%
Balance sheet
What the company owns and what it owes, at the end of each year. ₹ crore.
| Line item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 34 | 34 | 34 | 34 | 34 | 34 | 34 | 38 | 38 | 38 | 38 | 39 |
| Reserves | 473 | 1,010 | 1,096 | 1,343 | 1,615 | 1,665 | 1,901 | 2,576 | 2,792 | 3,209 | 3,660 | 3,967 |
| Borrowings | 1,220 | 1,022 | 758 | 717 | 793 | 617 | 724 | 786 | 1,029 | 4,983 | 5,571 | 4,989 |
| Other Liabilities | 285 | 524 | 691 | 776 | 944 | 995 | 1,067 | 1,385 | 1,573 | 3,066 | 2,453 | 2,299 |
| Minority Interest | 12 | 13 | ||||||||||
| Total Liabilities | 2,012 | 2,590 | 2,580 | 2,871 | 3,387 | 3,311 | 3,726 | 4,785 | 5,433 | 11,295 | 11,722 | 11,295 |
| Fixed Assets | 851 | 1,416 | 1,388 | 1,399 | 1,500 | 1,640 | 1,742 | 1,934 | 1,968 | 6,892 | 6,595 | 7,128 |
| CWIP | 80 | 80 | 80 | 67 | 175 | 306 | 267 | 175 | 1,130 | 433 | 732 | 583 |
| Investments | 86 | 228 | 291 | 316 | 362 | 155 | 196 | 588 | 234 | 433 | 516 | 464 |
| Other Assets | 995 | 867 | 822 | 1,090 | 1,350 | 1,210 | 1,521 | 2,087 | 2,101 | 3,537 | 3,879 | 3,119 |
| Total Assets | 2,012 | 2,590 | 2,580 | 2,871 | 3,387 | 3,311 | 3,726 | 4,785 | 5,433 | 11,295 | 11,722 | 11,295 |
Cash flows
Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.
| Line item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 35 | 422 | 346 | 293 | 290 | 532 | 385 | 290 | 504 | 1,105 | 760 | 1,576 |
| Cash from Investing Activity | -68 | -121 | -36 | -34 | -278 | -107 | -203 | -541 | -552 | -4,214 | -690 | -675 |
| Cash from Financing Activity | 34 | -262 | -337 | -110 | -70 | -389 | -180 | 217 | -31 | 3,381 | -64 | -990 |
| Net Cash Flow | 1 | 39 | -27 | 148 | -58 | 36 | 3 | -34 | -78 | 272 | 6 | -89 |
| Free Cash Flow | 2 | 388 | 306 | 198 | 58 | 301 | 271 | -16 | -392 | 573 | -4.36 | 851 |
Ratios
How fast customers pay, how long stock sits, and how well capital earns — year by year.
| Line item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 77 | 84 | 88 | 74 | 68 | 66 | 97 | 91 | 70 | 97 | 78 | 62 |
| Inventory Days | 56 | 66 | 72 | 68 | 73 | 54 | 101 | 70 | 48 | 82 | 80 | 65 |
| Days Payable | 28 | 74 | 123 | 88 | 81 | 70 | 134 | 106 | 80 | 147 | 100 | 92 |
| Cash Conversion Cycle | 105 | 77 | 37 | 54 | 60 | 51 | 64 | 55 | 38 | 32 | 57 | 35 |
| Working Capital Days | -34 | -80 | -57 | -34 | -1 | -4 | 15 | 17 | 4 | -11 | -24 | -40 |
| ROCE % | 6 | 6 | 11 | 17 | 25 | 16 | 17 | 18 | 17 | 14 | 12 | 8 |
Price trend
The price as a Renko brick chart: small moves drop out so the bigger path stands out.
Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.
Open interestPRO
Where option traders are positioned on this stock.
Industry numbers
The numbers that matter most in this industry, from the company's own filings.
1 when an audit qualification is filed as repetitive
0.00flag
2026-03-31
the company's own unlisted debt securities in default at period end
0.00cr
2026-06-30
exports as % of revenue
81.00
the company's own loans / revolving facilities in default at period end (standalone filing)
0.00cr
2026-06-30
net debt from the filed balance sheet at the newest year end: Borrowings − Cash Equivalents − Investments (Current); negative = net cash
4,701inr_cr
2026-03-31
guarantees / comfort given for promoter, promoter group, directors and KMP
0.00cr
2026-03-31
loans outstanding to promoter, promoter group, directors and KMP (governance filing)
0.00cr
2026-03-31
security given for the borrowing of promoter, promoter group, directors and KMP
0.00cr
2026-03-31
FY revenue / permanent employees + workers, same basis (calc)
4,13,04,074inr
2026-03-31
News
News and filings about PCBL Chemical Limited. Open one to see why it matters.
No recent news for this company.
Supply chain
Who it buys from, sells to and competes with — as recorded in our map of company links.
Competes with
Uses as raw material
- Carbon Black Feedstock oil (CBFS/PFS/SFS)
- Coal tar
Depends on the price of
- Crude Oil Brent
Sells to
- Apollo Tyres Limited · Carbon black (rubber grade) for tyre manufacturing
- CEAT Limited · Carbon black (rubber grade) for tyre manufacturing
- JK Tyre & Industries Limited · Carbon black (rubber grade) for tyre manufacturing
- MRF Limited · Carbon black (rubber grade) for tyre manufacturing
Buys from
- Kilburn Engineering Limited · Dryers for carbon black
- Ruchi Infrastructure Limited · storage/handling services for carbon black feed stock / liquid bulk chemicals
- Zaggle Prepaid Ocean Services Limited · spend management SaaS, prepaid/commercial cards and rewards solutions
About
What the company is, from our own records: where it sits, where it makes things, and what it is made of.
- Sector
- Chemicals
- Industry
- Carbon Black
- Classification
- Chemicals › Carbon Black
- ISIN
- INE602A01031
Business segments
- Carbon Black · 78%
- Chemical · 17%
- Power · 4%
Plants
- PCBL Chennai Carbon Black Plant
- PCBL Durgapur Carbon Black Plant
- PCBL Kochi Carbon Black Plant
- PCBL Mundra Carbon Black Plant
- PCBL Palej Carbon Black Plant
News impact
Big market events that reach PCBL Chemical Limited, and how the effect spreads.
23 Sept, 07:38 IST · Market event · medium impact
India starts anti-dumping probe into Chinese Glycine imports
India is probing cheap Chinese glycine imports, which could help home chemical makers later but may raise costs for food, drug and farm buyers if an import tax follows.
Who it hits first
- India's trade investigator (DGTR, the body that checks unfair imports) opened a probe into cheap glycine, a simple chemical used in food, drugs and farm sprays, arriving from China.
- If the probe finds harm to local makers, India can add an import tax (anti-dumping duty) that makes Chinese glycine costlier and helps home producers sell more.
- No listed glycine maker is named in the evidence, so any stock lift today is hope of future protection, while buyers of glycine could later pay more.
Who may gain
- Indian glycine and nearby specialty makers, if a duty lifts local prices (no single listed maker confirmed in the pack)
- Farm-chemical sellers such as PI Industries and GSP Crop, if protection spreads to agro inputs
Along the supply chain
Downstream
Indian food, drug and farm-spray makers that buy glycine could face higher input costs if cheap Chinese supply is taxed.
Upstream
Chinese glycine exporters face the probe; if a duty follows, their shipments to India shrink.
Where demand moves
Business
No extra orders yet — the probe only starts the case; real business gain comes months later if a duty curbs Chinese supply and buyers switch to home makers.
Capital
No fresh funds flow; investors may bid up chemical shares on protection hopes, but cash gains arrive only if duties lift prices and profits.
How it spreads across sectors
Chemicals
Small positive mood for home makers on protection hopes; real gains only if a duty lands.
Pharma
Mild cost worry since glycine feeds drugs; dearer supply would squeeze pill makers later.
Textiles
Negligible near-term link; fibre makers watch only for broader China-duty mood.
A pattern seen before
Cascade chain
- DGTR probes Chinese glycine dumping → possible import duty
- Duty curbs cheap imports → domestic glycine prices firm
- Chemical makers gain share → pharma and textile buyers face higher costs
Pattern name
China Cascade
Patterns
- China Cascade
Sectors queried
- Pharma
- Textiles
When it plays out
Immediate
1–7 days: chemical shares drift on protection hopes with no order change.
Medium term
1–6 months: probe findings decide any duty; only then do prices, orders and margins move.
Short term
1–4 weeks: filings and hearing news set expectations; buyers watch for price hints.
15 Sept, 18:45 IST · Market event · medium impact
India, China start discussions on trade concerns
India and China have started fresh trade talks, but with nothing agreed yet no company gains or loses; chemical and metal makers face import risk while drug and electronics firms could gain cheaper inputs if deals follow.
Who it hits first
- India and China have started a fresh round of talks on trade concerns and supply chains, with more meetings expected. Nothing has been agreed or changed yet - no duties cut, no bans lifted, no orders signed - so no listed company gains or loses any business today. The companies most exposed if talks eventually change the rules are chemical makers facing Chinese imports, drug makers buying Chinese raw materials, metal makers watched for dumping, textile traders, and electronics firms using Chinese parts.
Who may gain
- Nobody benefits yet - talks alone create no winners. If later rounds cut import friction, Indian buyers of Chinese inputs (drug makers needing bulk drugs, electronics assemblers needing parts) would pay less and earn more. If talks instead tighten protections, domestic chemical and metal makers shielded from Chinese goods would gain pricing power. Both paths are months away at best.
Along the supply chain
Downstream
Indian makers that consume Chinese inputs - drug formulators, electronics assemblers, pigment and dye users - could see lower input costs months from now if barriers fall; until then their supply and costs are unchanged.
Upstream
Chinese suppliers of raw materials (bulk drugs, electronic parts, specialty chemicals) could see steadier Indian demand if ties normalize, but no purchase-order changes until deals are signed.
Where demand moves
Business
No business demand moves yet: no buyer has new orders and no supplier has lost any, because the talks changed no rule. The path to watch is import policy - easier Chinese imports would shift orders from Indian chemical and carbon-black makers toward Chinese suppliers, while tighter rules would do the reverse.
Capital
No capital rotation is warranted on talks alone; money typically waits for duty or policy outcomes. At most, a light sympathy bid may touch large China-exposed importers, while domestic producers facing import risk may see mild caution selling - both likely to fade within days without follow-up news.
How it spreads across sectors
Chemicals
Pigment, dye and carbon-black makers compete directly with Chinese imports, so any easing of duties would squeeze their prices; no change yet.
Consumer Durables
Electronics assemblers using Chinese parts could gain cheaper inputs over time; gold jewellery has almost no China linkage.
Healthcare
Drug makers rely on Chinese bulk-drug imports, so smoother ties could slowly lower input costs; no change yet.
Metals & Mining
Steel and metal makers stay on dumping watch; talks could loosen or tighten the shield, direction unknown.
Textiles
Yarn and fabric trade flows both ways, so normalized ties are mildly helpful; nothing concrete yet.
A pattern seen before
Cascade chain
- Talks reopen - no duty or policy change yet
- Chemicals: pigment, dye and carbon-black makers face Chinese import risk if barriers ease
- Healthcare: drug formulators could gain cheaper bulk-drug inputs over time
- Metals & Mining: steel dumping watch stays either way
- Textiles and electronics: two-way trade mildly helped by normalized ties
Pattern name
China Cascade
Sectors queried
- Chemicals
- Healthcare
- Metals & Mining
- Textiles
- Consumer Durables
When it plays out
Immediate
In the next 1-7 days expect sentiment-only noise of about 1-2% on the most exposed names, fading fast without follow-up headlines.
Medium term
Over 1-6 months, if deals are struck, duty changes could move chemical, metal and drug stocks several percent; if talks stall, the story dies with no trace.
Short term
Over 1-4 weeks watch meeting readouts for any mention of duties, import curbs or market access - that is what would turn this story into real signals.
16 Jul, 04:25 IST · Market event · high impact
US Senate bill proposes up to 100% tariffs on Indian goods over India's Russian oil purchases
Who it hits first
- Indian goods exporters to the US face a tariff overhang: pharma generics (AUROPHARMA, DRREDDY, SUNPHARMA), textiles/apparel & home textiles (WELSPUNLIV, GOKEX, KPRMILL), specialty/carbon-black chemicals (PCBL, ACI). IT services (TCS/INFY/HCLTECH/WIPRO) are largely exempt as tariffs apply to goods, not services.
Who may gain
- Exporters domiciled in non-targeted countries and India's domestic-demand plays that do not ship goods to the US; India-UK FTA (in force) offers textile exporters a partial diversification offset.
Along the supply chain
Downstream
US retailers/distributors of Indian textiles and pharmacies dependent on Indian generics face higher landed costs and potential supply gaps.
Upstream
Indian cotton ginners/yarn spinners and API/intermediate suppliers to the exporters would see softer downstream order pull if US demand is curtailed.
Where demand moves
Business
If enacted, US importers substitute Indian goods (apparel, generics, carbon black) with suppliers from non-targeted countries, shifting order volumes away from Indian exporters; drug shortages could force partial US carve-outs that blunt the pharma hit.
Capital
Risk-off rotation out of US-export-heavy exporters (textiles, mid-cap chemicals) toward domestic-consumption and rate-sensitive names insulated from US trade; quality large-cap IT (cheap, services-exempt) acts as a relative safe harbour within the export basket.
How it spreads across sectors
Chemicals
US-export chemical margin risk
IT Services
indirect sentiment/rupee only — no direct goods levy
Pharma
US-generics margin/volume risk if enacted (exemptions likely)
Textiles
US apparel/home-textile order risk, partly offset by UK FTA
codex additions
- Oil Refining and Marketing
- Aviation
- Paints, Tyres and Plastic Products
- Ports, Shipping and Logistics
- Banks and Trade Finance
- Metals, Engineering and Capital Goods Exporters
- Seafood, Rice, Spices and Agri Exports
- Packaging and Paper
- Defence and Strategic Manufacturing
When it plays out
Immediate
Shallow, mean-reverting risk-off dip in export-heavy names on headline risk (as on 2025-08-05)
Medium term
Outcome hinges on enactment + presidential waiver and whether India curbs Russian crude; product carve-outs likely for essential drugs
Short term
Direct goods exporters (textiles, carbon black) stay pressured while the bill's passage and waiver stance are debated
Other sectors it reaches
- {"causal_chain":"Tariff threat is tied to Russian crude purchases -\u003e policy pressure to cut Russian crude share -\u003e loss of discounted crude feedstock and more expensive sourcing from Middle East/US -\u003e weaker refining/marketing margins and possible fuel-price policy friction.","direction":"negative","example_tickers":["RELIANCE","IOC","BPCL"],"magnitude":"large","notes":"Most exposed if India materially reduces Russian barrels; impact partly offset if refiners can pass through higher costs. [Codex Layer 5.5]","sector":"Oil Refining and Marketing","time_horizon":"1_to_6_months"}
- {"causal_chain":"Reduced Russian crude discounts or higher crude risk premium -\u003e higher ATF costs -\u003e margin pressure for airlines, especially if fares cannot fully adjust during weak demand periods.","direction":"negative","example_tickers":["INDIGO","SPICEJET"],"magnitude":"medium","notes":"Fuel is a major airline cost; direction depends on crude move and fare discipline. [Codex Layer 5.5]","sector":"Aviation","time_horizon":"1_to_4_weeks"}
- {"causal_chain":"Crude-linked input basket rises if India loses discounted crude advantage -\u003e petrochemical derivatives, rubber, solvents and packaging costs increase -\u003e gross margin pressure for downstream manufacturers.","direction":"negative","example_tickers":["ASIANPAINT","BERGEPAINT","APOLLOTYRE"],"magnitude":"medium","notes":"Companies with pricing power may recover margins with a lag. [Codex Layer 5.5]","sector":"Paints, Tyres and Plastic Products","time_horizon":"1_to_4_weeks"}
- {"causal_chain":"Tariff uncertainty -\u003e lower US-bound goods volumes in textiles, chemicals, auto parts and pharma -\u003e reduced container throughput and freight activity; crude sourcing shifts could also alter tanker route economics.","direction":"mixed","example_tickers":["ADANIPORTS","CONCOR","BLUEDART"],"magnitude":"medium","notes":"Container/export logistics negative; crude-routing changes may create pockets of offsetting activity. [Codex Layer 5.5]","sector":"Ports, Shipping and Logistics","time_horizon":"1_to_6_months"}
- {"causal_chain":"Exporters face order deferrals, receivable delays and inventory buildup -\u003e higher working-capital needs and credit risk -\u003e pressure on lenders with MSME/exporter exposure and trade-finance books.","direction":"negative","example_tickers":["SBIN","AXISBANK","FEDERALBNK"],"magnitude":"small","notes":"Systemic impact likely limited unless tariffs are enacted and sustained. [Codex Layer 5.5]","sector":"Banks and Trade Finance","time_horizon":"1_to_6_months"}
- {"causal_chain":"Broad tariff threat on Indian goods -\u003e US buyers may delay sourcing decisions beyond listed sectors -\u003e pressure on engineering goods, industrial components and metal product exports.","direction":"negative","example_tickers":["HINDALCO","APLAPOLLO","BHEL"],"magnitude":"medium","notes":"More relevant for companies with direct or indirect US goods exposure. [Codex Layer 5.5]","sector":"Metals, Engineering and Capital Goods Exporters","time_horizon":"1_to_6_months"}
- {"causal_chain":"Tariffs on Indian goods would hit price-sensitive food exports -\u003e US importers switch to Vietnam, Thailand, Ecuador or other suppliers -\u003e demand and margin pressure on Indian agri/food exporters.","direction":"negative","example_tickers":["AVANTIFEED","KRBL","LTFOODS"],"magnitude":"medium","notes":"Seafood and specialty food exports can be highly tariff-sensitive. [Codex Layer 5.5]","sector":"Seafood, Rice, Spices and Agri Exports","time_horizon":"1_to_6_months"}
- {"causal_chain":"Export slowdown in textiles, pharma, chemicals, food and consumer goods -\u003e lower demand for cartons, labels, flexible packaging and export-grade packaging materials.","direction":"negative","example_tickers":["UFLEX","TCPLPACK","JKPAPER"],"magnitude":"small","notes":"Second-order volume impact; domestic demand cushions downside. [Codex Layer 5.5]","sector":"Packaging and Paper","time_horizon":"1_to_6_months"}
- {"causal_chain":"US-India trade friction over Russia ties -\u003e risk of slower strategic cooperation, procurement clearances or technology-transfer sentiment -\u003e uncertainty for defence and aerospace supply-chain names.","direction":"mixed","example_tickers":["HAL","BEL","BDL"],"magnitude":"small","notes":"Negative if diplomatic friction deepens; positive if India accelerates domestic indigenisation. [Codex Layer 5.5]","sector":"Defence and Strategic Manufacturing","time_horizon":"1_to_6_months"}
28 Jun, 14:13 IST · Market event · medium impact
Board of Trade to meet on July 3 to discuss ways to boost exports
Who it hits first
- Export-oriented manufacturers in Textiles, Chemicals and Engineering/Capital Goods could see a sentiment lift on hopes of fresh export incentives; no concrete measure is announced — the July 3 meeting is a consultation.
Who may gain
- High export-revenue chemical exporters PCBL (81% export revenue, carbon black) and ACI (79% export revenue, marine specialty chemicals)
Along the supply chain
Downstream
Global tyre manufacturers (PCBL carbon black) and overseas specialty-chemical buyers (ACI bromine, industrial salt) are the export customers; export facilitation could ease their order flow but nothing changes until concrete measures are notified.
Upstream
Carbon-black feedstock (CBFS) suppliers to PCBL and bromine/marine-chemical input providers to ACI would see higher offtake only if export volumes actually rise after an incentive; a consultation produces no immediate change.
Where demand moves
Business
A concrete export incentive would route incremental external demand to high-export-share manufacturers (PCBL ~81%, ACI ~79%) via better price realisation and duty drawback; lower-export-share peers benefit proportionally less. Until a measure lands, business demand is unchanged.
Capital
Sentiment-driven rotation into export-themed mid-cap manufacturing (Textiles, Chemicals, Capital Goods) on incentive hopes; the flow reverses if the July 3 meeting yields no concrete measure.
How it spreads across sectors
Capital Goods
Positive on engineering-goods export-promotion focus
Chemicals
Positive — high-export chemical names are direct read-throughs
Textiles
Positive on hopes of export incentives (RoDTEP, interest equalisation) for a labour-intensive export sector
codex additions
When it plays out
Immediate
Mild positive sentiment for high-export names ahead of the July 3 meeting; no earnings change
Medium term
Only a notified, funded incentive with clear eligibility and pass-through would translate into actual margin/order uplift for export-oriented manufacturers
Short term
Reaction hinges on whether the July 3 meeting yields concrete measures (RoDTEP enhancement, freight/interest subsidy); absent specifics, sentiment fades
Other sectors it reaches
- {"causal_chain":"Export-boost consultation could include faster clearances, market-access support, logistics relief or incentive continuity for high-value regulated exports; pharma and API exporters benefit from lower friction and improved policy visibility.","direction":"positive","example_tickers":["SUNPHARMA","CIPLA","DIVISLAB"],"magnitude":"medium","notes":"Benefit is sentiment-led unless specific measures address regulated-market approvals, APIs or freight costs.","sector":"Pharmaceuticals \u0026 APIs","time_horizon":"1_to_4_weeks"}
- {"causal_chain":"A broad export-promotion agenda may extend beyond goods to services exports; any signals on tax clarity, SEZ/GIFT City facilitation, skilling or global market access can support IT and business-service exporters.","direction":"positive","example_tickers":["TCS","INFY","HCLTECH"],"magnitude":"small","notes":"Less direct than manufacturing because the meeting framing often focuses on merchandise exports.","sector":"IT Services","time_horizon":"1_to_6_months"}
- {"causal_chain":"Export push typically raises focus on port efficiency, freight subsidies, customs digitisation and trade corridors; higher export volumes or lower turnaround bottlenecks can lift logistics and port operators.","direction":"positive","example_tickers":["ADANIPORTS","CONCOR","BLUEDART"],"magnitude":"medium","notes":"Upside depends on whether policy measures target freight cost, container availability or port dwell times.","sector":"Logistics, Ports \u0026 Shipping","time_horizon":"1_to_6_months"}
- {"causal_chain":"Gems and jewellery are major export categories; measures on duty drawback, trade financing, gold import procedures or market promotion could improve margins and order visibility.","direction":"positive","example_tickers":["TITAN","KALYANKJIL","SENCO"],"magnitude":"medium","notes":"Listed pure-play export exposure is limited; many large exporters are unlisted, so ticker mapping is imperfect.","sector":"Gems \u0026 Jewellery","time_horizon":"1_to_4_weeks"}
- {"causal_chain":"Engineering export support can spill into auto ancillaries through incentives for component exports, quality certification support, FTAs and lower logistics costs; global OEM supply-chain diversification also amplifies the link.","direction":"positive","example_tickers":["MOTHERSON","BOSCHLTD","BHARATFORG"],"magnitude":"medium","notes":"More relevant for companies with sizeable overseas revenue or export-oriented component lines.","sector":"Auto Components","time_horizon":"1_to_6_months"}
- {"causal_chain":"Export-growth policy may prioritize electronics as a strategic category; faster customs, component ecosystem support, PLI alignment or export-credit measures can aid EMS and consumer-electronics supply chains.","direction":"positive","example_tickers":["DIXON","KAYNES","SYRMA"],"magnitude":"medium","notes":"Potentially large if the discussion leads to concrete electronics-export facilitation, but consultation alone is only a sentiment trigger.","sector":"Electronics Manufacturing \u0026 EMS","time_horizon":"1_to_6_months"}
- {"causal_chain":"Export incentives often involve interest equalisation, working-capital support, export credit insurance and forex services; banks with strong SME/exporter books may see incremental credit demand and fee income.","direction":"mixed","example_tickers":["SBIN","HDFCBANK","ICICIBANK"],"magnitude":"small","notes":"Positive from credit demand and fees, but subsidised lending or directed-credit schemes can limit margin upside.","sector":"Banks \u0026 Trade Finance","time_horizon":"1_to_6_months"}
- {"causal_chain":"Higher export volumes in textiles, pharma, chemicals, food and consumer goods increase demand for cartons, labels, flexible packaging and compliant export-grade materials.","direction":"positive","example_tickers":["UFLEX","TCPLPACK","JKPAPER"],"magnitude":"small","notes":"Second-order volume benefit; commodity input costs can offset margin gains.","sector":"Packaging \u0026 Paper","time_horizon":"1_to_6_months"}
- {"causal_chain":"Export-promotion measures may target processed foods, marine products, rice, spices and value-added agriculture through market access, certification support and cold-chain logistics.","direction":"positive","example_tickers":["LTFOODS","KRBL","AVANTIFEED"],"magnitude":"medium","notes":"Policy details matter because agri exports are also exposed to domestic price-control and export-restriction risk.","sector":"Food Processing \u0026 Agri Exports","time_horizon":"1_to_6_months"}
Dividends, splits & big trades
Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.
Dividends
| 4 Aug 2026 | interim | ₹4.5 |
|---|---|---|
| 27 Oct 2025 | interim | ₹6 |
| 16 Jan 2025 | interim | ₹5.5 |
| 29 Jan 2024 | interim | ₹5.5 |
| 10 Feb 2023 | interim | ₹5.5 |
| 11 Apr 2022 | split | ₹0 |
| 1 Feb 2022 | interim | ₹10 |
| 1 Feb 2021 | interim | ₹7 |
Splits, bonuses & buybacks
- daily-prices repair: 8 rows from NSE's archive (replace 2, delete 1, insert 5), 2023-11-12..2026-02-01 (docs/flat_day_repair.md)1× · 12 Nov 2023
Bulk & block deals
| Date | Who | Bought / sold | Shares | Price |
|---|---|---|---|---|
| 29 Jul 2026 | MICROCURVES TRADING PRIVATE LIMITED | BUY | 19,70,820 | ₹358.98 |
| 29 Jul 2026 | MICROCURVES TRADING PRIVATE LIMITED | SELL | 19,70,820 | ₹359.24 |
Documents
Annual reports, results presentations and earnings calls, straight from the source.
- Annual report · 2025-2626 Aug 2026
- Earnings call6 Aug 2026
- Earnings call · Q1FY2729 Jul 2026
- Earnings call · Q4FY2630 Apr 2026
- Earnings call · Q3FY263 Feb 2026
- Earnings call · Q2FY2617 Oct 2025
- Annual report · 2024-2516 Sep 2025
Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.